Skip to content
Loading...

In addition to the much anticipated scientific programme, EASL Studio is broadcasting LIVE from the congress, in Milan. This year you can follow the sessions on site, in the Hepatology Arena, or here online on this page.

Programme

09:45 -10:15 CEST  Buongiorno Milano: What not to miss during EASL Congress

Aleksander Krag (Moderator), Debbie Shawcross (Faculty), Thomas Berg (Faculty), Ahmed Elsharkawy (Faculty)

13:15 – 13:45 CEST Advances in systemic treatments in liver cancer

Josep Llovet (Moderator), Massimo Iavarone (Faculty), Matthias Pinter (Faculty), Jessica Zucman-Rossi (Faculty)

16:45 – 17:15 CEST MASLD anno 2024: A rapidly changing landscape

Sven Francque (Moderator), Asad Izzidin Dajani (Sanofi representative), Becky Taub (Madrigal Pharmaceuticals representative), Judith Ertle (Boehringer Ingelheim representative),

This EASL Studio is supported by Boehringer Ingelheim, GSK, Madrigal Pharmaceuticals, NovoNordisk, and Sanofi

                  

10:00 – 10:30 CEST Breaking boundaries: Innovating the future of hepatitis B and D treatment together

Thomas Berg (Moderator), Larry Blatt (Aligos representative), Todd Correll (VIR representative), Susan Dixon (GSK representative), Simon Fletcher (Gilead representative)

This EASL Studio is supported by Aligos, Gilead, GSK and VIR

    Gilead-logo   

12:30 – 13:00 CEST Education at the heart of EASL’s mission

Sven Francque (Moderator), Krista Rombouts (Faculty), Rajeshwar Mookerjee (Faculty), Henning Grønbæk (Faculty)

16:15 – 16:45 PBC roundtable

Verena Keitel (Moderator), Carrie Frenette (CymaBay Therapeutics representatives), Tiago Nunes (Mirum representative), Dimitar Tonev (Ipsen representative), Phil Troke (GSK representative)

This EASL Studio is supported by CymaBay Therapeutics, GSK, IPSEN, and Mirum.

            

10:00 – 10:30 CEST SLD nomenclature: Need for refinement?

Aleksander Krag (Moderator), Meena Bansal (Faculty), Sven Francque (Faculty), Alexandre Louvet (Faculty)

12:30 – 13:00 CEST Exploring new frontiers: The AI liver taskforce initiative

Eric Trépo (Moderator), Thomas Marjot (Faculty), Jakob Kather (Faculty), Raquel Pérez-López (Faculty)

 

13:30 – 14:00 CEST Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention

Debbie Shawcross (Moderator), Paolo Angeli (Faculty), Salvador Augustin (Boehringer Ingelheim representative), Paolo Caraceni (CSL Behring representative)

This EASL Studio is supported by Boehringer Ingelheim, and CSL Behring

     

 

16:30 – 17:00 CEST Unlocking breakthroughs: Pioneering drug development for ALD and MetALD

Aleksander Krag (Moderator), Mazen Noureddin (Faculty), Michelle Long (NovoNordisk representative), Nikhil Vergis (GSK representative)

This EASL Studio is supported by Boehringer Ingelheim, GSK, Madrigal Pharmaceuticals, NovoNordisk, and Sanofi

        

12:30 – 13:00 CEST Landmark studies at EASL Congress 2024

Thomas Berg (Moderator), Rajiv Jalan (Faculty), Verena Keitel (Faculty), Frank Tacke (Faculty)

15:45 – 16:15 CEST Arrivederci Milano, hallo Amsterdam!

Aleksander Krag (Moderator), Debbie Shawcross (Moderator), Cyrielle Caussy (Faculty), Ana Lleo (Faculty), Jean-Charles Nault (Faculty), Francesco Negro (Faculty), Vlad Ratziu (Faculty), Virginia Hernández-Gea (Faculty)

Back To Top